2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Brain Neoplasms
4
Lung Neoplasms
3
Glioma
3
Carcinoma, Non-Small-Cell Lung
3
Small Cell Lung Carcinoma
2
Sarcoma
2
Neoplasms
2
Liver Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Stage III Lung Non-Small Cell Cancer AJCC v7
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Meningioma
1
Melanoma
1
Liver Cirrhosis
1
Laryngeal Neoplasms
1
Hypoxia
1
Interventions
Temozolomide
115
Radiotherapy
63
Magnetic Resonance Spectroscopy
30
Carboplatin
30
Bevacizumab
30
Carmustine
28
Filgrastim
23
Surgical Procedures, Operative
22
Irinotecan
22
Radiation
18
Lomustine
17
Vincristine
15
Etoposide
15
Specimen Handling
13
Peripheral Blood Stem Cell Transplantation
13
O(6)-benzylguanine
13
Radiotherapy, Intensity-Modulated
12
Procarbazine
11
Erlotinib Hydrochloride
11
Cyclophosphamide
11
Chemotherapy, Adjuvant
11
sargramostim
10
Thiotepa
10
Cisplatin
10
Flucytosine
9
Everolimus
9
antineoplaston AS 2-1
8
antineoplaston A10
8
Granulocyte Colony-Stimulating Factor
8
Vorinostat
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Astrocytoma
×
fluoromisonidazole
×
Clear all
NCT01868906
2018-08-24
FMISOPETSCS
Dr. Negrin University Hospital
Phase 2
Terminated
6 enrolled